Lipid-based formulations for intestinal lymphatic delivery.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0928-0987(02)00051-9PMID 12036717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice.

  2001cited by this paper
• Comparison of the lymphatic transport of a lipophilic drug from vehicles containing α‐tocopherol and/or triglycerides in rats

  2001cited by this paper
• Comparison of the Lymphatic Transport of Halofantrine Administered in Disperse Systems Containing Three Different Unsaturated Fatty Acids

  2001cited by this paper
• A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.

  2001cited by this paper
• Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.

  2001cited by this paper
• Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

  2000cited by this paper
• Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs.

  2000cited by this paper
• A proposed model for the assembly of chylomicrons.

  2000cited by this paper
• Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.

  2000cited by this paper
• Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection.

  2000cited by this paper
• Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.

  2000cited by this paper
• Caco-2 cells secrete two independent classes of lipoproteins with distinct density: effect of the ratio of unsaturated to saturated fatty acid.

  2000cited by this paper
• SO YOU WANT TO USE LIPID-BASED FORMULATIONS IN DEVELOPMENT

  1999cited by this paper
• Assembly and Secretion of Chylomicrons by Differentiated Caco-2 Cells

  1999cited by this paper
• Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein

  1999cited by this paper
• Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

  1999cited by this paper
• Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)

  1999cited by this paper
• Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers

  1999cited by this paper
• Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.

  1998cited by this paper
• Hyposecretion of biliary phospholipids (PL) significantly decreases the intestinal absorption of cholesterol (Ch) in Mdr2(−/−) and (+/−) mice

  1998cited by this paper
• Lipoprotein secretion by intestinal Caco-2 cells is affected differently by trans and cis unsaturated fatty acids: effect of carbon chain length and position of the double bond.

  1998cited by this paper
• A general pattern for substrate recognition by P-glycoprotein.

  1998cited by this paper
• Endogenous lipase activity in Caco-2 cells.

  1998cited by this paper
• Lymphatic uptake of MK-386, a sterol 5α-reductase inhibitor, from aqueous and lipid formulations

  1998cited by this paper
• Participation of the microsomal triglyceride transfer protein in lipoprotein assembly in Caco-2 cells: interaction with saturated and unsaturated dietary fatty acids.

  1998cited by this paper
• Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum.

  1998cited by this paper
• A study of the uptake and lymphatic transport of lipid in the mouse

  1998cited by this paper
• Uptake of drugs into the intestinal lymphatics after oral administration

  1997cited by this paper
• Drug delivery to the lymphatic system.

  1997cited by this paper
• Microsomal triglyceride transfer protein in CaCo-2 cells: characterization and regulation.

  1997cited by this paper
• Lipid-based vehicles for the oral delivery of poorly water soluble drugs

  1997cited by this paper
• Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

  1997cited by this paper
• Potential for lymphatic targeting of peptides

  1997cited by this paper
• Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.

  1997cited by this paper
• The role of mdr2 P‐glycoprotein in hepatobiliary lipid transport

  1997cited by this paper
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

  1997cited by this paper
• Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

  1996cited by this paper
• Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells.

  1996cited by this paper
• Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.

  1996cited by this paper
• The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System

  1996cited by this paper
• Lipophilic prodrugs designed for intestinal lymphatic transport

  1996cited by this paper
• Fatty acid uptake by Caco-2 human intestinal cells.

  1996cited by this paper
• Caco‐2 cells as a model for intestinal lipoprotein synthesis and secretion

  1995cited by this paper
• Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane

  1995cited by this paper
• Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein.

  1995cited by this paper
• Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy

  1995cited by this paper
• Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics

  1995cited by this paper
• Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects

  1995cited by this paper
• Palmitic acid and linoleic acid metabolism in Caco-2 cells: different triglyceride synthesis and lipoprotein secretion.

  1995cited by this paper
• Physiology of the Gastrointestinal Tract

  1994cited by this paper
• Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach

  1994cited by this paper
• The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

  1994cited by this paper
• Alkaline lipase in rat intestinal mucosa: physiological parameters.

  1993cited by this paper
• Nutritional control of fatty acid esterification in differentiating Caco-2 intestinal cells is mediated by cellular diacylglycerol concentrations.

  1993cited by this paper
• Deacylation-reacylation cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoylphosphatidylfluorouridine in rats.

  1993cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Effect of Oily Vehicles on Absorption of Mepitiostane by the Lymphatic System in Rats

  1992cited by this paper
• Lymphatic Transport of Drugs

  1992cited by this paper
• Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene

  1992cited by this paper
• Blood and lymph transport of DDT after oral and parenteral administration to anaesthetised rats

  1991cited by this paper
• Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings.

  1990cited by this paper
• Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings.

  1990cited by this paper
• Size and shape determination of fixed chylomicrons and emulsions with fluid or solid surfaces by three-dimensional analysis of shadows.

  1990cited by this paper
• Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches

  1990cited by this paper
• A rapid method for staining large chylomicrons.

  1989cited by this paper
• Regulation of triglyceride-rich lipoprotein secretion by fatty acids in CaCo-2 cells.

  1988cited by this paper
• Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein.

  1988cited by this paper
• Factors regulating the formation of chylomicrons and very-low-density lipoproteins by the rat small intestine.

  1987cited by this paper
• Effect of administration route on the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles.

  1986cited by this paper
• Formation and transport of chylomicrons by enterocytes to the lymphatics.

  1986cited by this paper
• Effect of saturated and unsaturated lipid on the composition of mesenteric triglyceride-rich lipoproteins in the rat.

  1986cited by this paper
• Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules

  1986cited by this paper
• An experimental system designed to study the in situ intestinal lymphatic transport of lipophilic drugs in anesthetized rats

  1986cited by this paper
• Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes.

  1985cited by this paper
• Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine.

  1984cited by this paper
• Pluronic L-81: a potent inhibitor of the transport of intestinal chylomicrons.

  1984cited by this paper
• Lipid digestion and absorption.

  1983cited by this paper
• Maximal lymphatic triglyceride transport rate from the rat small intestine.

  1982cited by this paper
• The effect of oils on the lymphatic absorption of DDT

  1982cited by this paper
• Bifunctional delivery system for selective transfer of bleomycin into lymphatics via enteral route

  1981cited by this paper
• The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell.

  1976cited by this paper
• Chylomicron formation and composition in unanaesthetised rabbits.

  1975cited by this paper
• The effect of dietary fat load on the size and composition of chylomicrons in thoracic duct lymph.

  1968cited by this paper
• FATTY ACID ESTERIFICATION AND CHYLOMICRON FORMATION DURING FAT ABSORPTION IN RAT. 3. POSITIONAL RELATIONS IN TRIGLYCERIDES AND LECITHIN.

  1965cited by this paper
• FATTY ACID ESTERIFICATION AND CHYLOMICRON FORMATION DURING FAT ABSORPTION. 2. PHOSPHOLIPIDS.

  1963cited by this paper

• Advanced Optimization of Clonazepam-Loaded Solid Self-Emulsifying Drug Delivery Systems: Comparison of Weighted Goal Programming and Desirability Function in a Quality by Design Framework

  2026cites this paper
• Droplet Size Reduction of Self-Emulsifying Drug Delivery System (SEDDS) Using the Hybrid of Medium and Long-Chain Triglycerides

  2025cites this paper
• Development and Characterization of Innovative Nifurtimox Formulations as Therapeutic Alternative for Chagas Disease

  2025cites this paper
• Leveraging Buprenorphine and Halofantrine as Tool Molecules to Develop a Novel Semi-Physiologically based Pharmacokinetic Model Accounting for Gastro-Intestinal Lymphatic Absorption and Enabling Cross-Species Translation

  2025cites this paper
• Impact of Microemulsion Oil Components on Liquid-Liquid Phase Separation of a Supersaturated Drug Revealed by Cryo-TEM and 1H NMR Analysis.

  2025cites this paper
• Overcoming Bioavailability Barriers: Optimized Hybrid Nanocarrier System to Amplify Berberine Absorption via Peyer’s Patches

  2025cites this paper
• Novel Approaches for the Enhancement of Bioavailability of Drugs: An Updated Review.

  2024cites this paper
• Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia

  2024cites this paper
• Development of a self-nanoemulsifying drug delivery system of diindolylmethane for enhanced bioaccessibility, bioavailability and anti-breast cancer efficacy

  2024cites this paper
• Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice

  2024influential citation
• Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake

  2023cites this paper
• Battle of the milky way: Lymphatic targeted drug delivery for pathogen eradication.

  2023cites this paper
• Lipid based drug delivery systems for oral, transdermal and parenteral delivery: Recent strategies for targeted delivery consistent with different clinical application

  2023cites this paper
• Inotodiol, an antiasthmatic agent with efficacy and safety, preferentially impairs membrane-proximal signaling for mast cell activation.

  2023cites this paper
• Critical aspects involved in lipid dispersion and digestion: Emphasis on in vitro models and factors influencing lipolysis of oral lipid based formulations.

  2023cites this paper
• Solidification of Self-Emulsifying Drug Delivery Systems as a Novel Approach to the Management of Uncomplicated Malaria

  2022cites this paper
• Optimized self-microemulsifying drug delivery system improves the oral bioavailability and brain delivery of coenzyme Q10

  2022cites this paper
• Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system

  2022cites this paper
• Design and Development of Solid SMEDDS and Liquisolid Formulations of Lovastatin, for Improved Drug Dissolution and In vivo Effects—a Pharmacokinetic and Pharmacodynamic Assessment

  2022cites this paper
• Solid Lipid Nanoparticles: A Potential Option for Enhancing Oral Bioavailability of Highly Soluble and Poorly Permeable (BCS Class III) Drugs.

  2022cites this paper
• Formulation and Characterization of Self-Microemulsifying Drug Delivery System (SMEDDS) of Sertraline Hydrochloride.

  2022cites this paper
• Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt’s Disease

  2022cites this paper
• Mechanisms Underlying the Impacts of Lipids on the Diverse Bioavailability of Per- and Polyfluoroalkyl Substances in Foods.

  2022cites this paper
• Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.

  2022cites this paper
• Advances in oral absorption of polysaccharides: Mechanism, affecting factors, and improvement strategies.

  2022cites this paper
• Effect of Gum Acacia on the Intestinal Bioavailability of n-3 Polyunsaturated Fatty Acids in Rats

  2022cites this paper
• Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development

  2022cites this paper
• Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos.

  2021cites this paper
• Adverse effects of linoleic acid: Influence of lipid oxidation on lymphatic transport of citrus flavonoid and enterocyte morphology.

  2021cites this paper
• Bioavailability of berberine: challenges and solutions

  2021cites this paper
• Design, development and in vivo pharmacokinetic evaluation of zotepine loaded solid lipid nanoparticles for enhanced oral bioavailability

  2021cites this paper
• Lipophilic salts and lipid-based formulations for bridging the food effect gap of venetoclax.

  2021cites this paper
• Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches

  2021cites this paper
• Black pepper and vegetable oil-based emulsion synergistically enhance carotenoid bioavailability of raw vegetables in humans.

  2021cites this paper
• Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC

  2021cites this paper
• Olanzapine Mesoporous Nanostructured Lipid Carrier: Optimization, Characterization, In Vivo Assessment, and Physiologically Based Pharmacokinetic Modeling

  2021cites this paper
• Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease.

  2021cites this paper
• Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.

  2021cites this paper
• In vitro lipolysis and physicochemical characterization of unconventional star anise oil towards the development of new lipid-based drug delivery systems

  2021cites this paper
• Lipid-based combinational drug delivery systems

  2021cites this paper
• Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.

  2021cites this paper
• An update on oral drug delivery via intestinal lymphatic transport

  2021cites this paper
• Nanoemulsion for improving the oral bioavailability of hesperetin: formulation optimization and absorption mechanism.

  2021cites this paper
• Balanced lipase interactions for degradation-controlled paclitaxel release from lipid cubic phase formulations.

  2021cites this paper
• Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies

  2021cites this paper
• Current approaches in lipid-based nanocarriers for oral drug delivery

  2021cites this paper
• Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic

  2021cites this paper
• FORMULATION AND IN VIVO EVALUATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM OF RAMIPRIL IN WISTAR RATS

  2021cites this paper
• Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide

  2021cites this paper
• Advances in Oral Drug Delivery

  2021cites this paper
• Considerations For Determining Direct Versus Indirect Functional Effects Of Solubilizing Excipients On Drug Transporters For Enahancing Bioavailability.

  2020cites this paper
• Pharmaceutical Cocrystal Development of TAK-020 with Enhanced Oral Absorption

  2020cites this paper
• Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis.

  2020cites this paper
• Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs

  2020cites this paper
• Benznidazole Self-Emulsifying Delivery System: A Novel Alternative Dosage Form For Chagas Disease Treatment.

  2020cites this paper
• Self-Nanoemulsifying Drug Delivery System to Enhance Solubility and Dissolution of Lipophilic Drug Repaglinide

  2020cites this paper
• Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties

  2020cites this paper
• A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive?

  2020cites this paper
• Solid-in-oil nanodispersions as a novel delivery system to improve the oral bioavailability of bisphosphate, risedronate sodium.

  2020cites this paper
• A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus

  2020cites this paper
• Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids

  2020cites this paper
• Quality by Design Approach for Development and Characterisation of 
Solid Lipid Nanoparticles of Quetiapine Fumarate

  2020cites this paper
• FORMULATION AND EVALUATION OF IN-SITU FORMING LIPOSOMES OF GLICLAZIDE

  2020cites this paper
• Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects

  2020cites this paper
• Design and Development of Darunavir loaded Self Micro Emulsifying Drug Delivery System using Extreme Vertices Mixture Design in a Quality by Design Framework

  2020cites this paper
• Intestinal lymphatic transport study of antitumor lead compound T-OA with liposomes.

  2020cites this paper
• Optimization of lipid materials in the formulation of S-carvedilol self-microemulsifying drug-delivery systems

  2020cites this paper
• Pharmaceutical nanotechnology: Brief perspective on lipid drug delivery and its current scenario

  2019cites this paper
• Design and in vivo Evaluation of Manidipine by Self-Nanoemulsifying Drug Delivery Systems

  2019cites this paper
• Development of Betamethasone Dipropionate-loaded Nanostructured Lipid Carriers for Topical and Transdermal Delivery

  2019cites this paper
• A SYSTEMATIC REVIEW ON SELF-MICRO EMULSIFYING DRUG DELIVERY SYSTEMS: A POTENTIAL STRATEGY FOR DRUGS WITH POOR ORAL BIOAVAILABILITY

  2019cites this paper
• DESIGN, DEVELOPMENT & EVALUATION OF SELF EMULSIFYING DRUG DELIVERY SYSTEM OF AMLODIPINE

  2019cites this paper
• Quantitative Prediction of Oral Bioavailability of a Lipophilic Antineoplastic Drug Bexarotene Administered in Lipidic Formulation Using a Combined In Vitro Lipolysis/Microsomal Metabolism Approach.

  2019cites this paper
• Self – Micro Emulsifying Drug Delivery System: A Potential Solution to the Challenges of Oral Delivery of Poorly Water – Soluble Drugs

  2019cites this paper
• Basic principles of drug delivery systems - the case of paclitaxel.

  2019cites this paper
• Solidified nanostructured lipid carrier (S-NLC) for enhancing the oral bioavailability of ezetimibe

  2019cites this paper
• Oral absorption and lymphatic transport of baicalein following drug–phospholipid complex incorporation in self-microemulsifying drug delivery systems

  2019cites this paper
• Can curcumin along with chemotherapeutic drug and lipid provide an effective treatment of metastatic colon cancer and alter multidrug resistance?

  2019cites this paper
• Evaluating (HBCD) toxicokinetics in humans and rodents by physiologically based pharmacokinetic modeling.

  2019cites this paper
• Role of Lipid-Based Drug Delivery System in Critical Oral Absorption :

  2019cites this paper
• Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans

  2019influential citation
• Development and in vivo evaluation of baicalin-loaded W/O nanoemulsion for lymphatic absorption

  2019cites this paper
• Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS

  2019cites this paper
• Improved in vivo performance and immunomodulatory effect of novel Omega-3 fatty acid based Tacrolimus nanostructured lipid carrier

  2019cites this paper
• Formulation Development, Statistical Optimization and Characterization of the Self-Microemulsifying Drug Delivery System (SMEDDS) of Irbesartan

  2019cites this paper
• Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.

  2019cites this paper
• Enhancing Curcumin Oral Bioavailability Through Nanoformulations

  2019cites this paper
• QbD-Based Development of Cationic Self-nanoemulsifying Drug Delivery Systems of Paclitaxel with Improved Biopharmaceutical Attributes

  2019cites this paper
• Self-microemulsifying Drug Delivery System for Problematic Molecules: An Update.

  2019cites this paper
• Self Emulsifying Drug Delivery Systems: Progress till now

  2019cites this paper
• Development of lipid matrix tablets containing a double-fixed dose combination of artemether and lumefantrine

  2019cites this paper
• DESIGN AND EVALUATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS OF MANIDIPINE FOR ENHANCEMENT OF SOLUBILITY

  2019cites this paper
• A spray dried Nelfinavir Mesylate particles for enhanced oral bioavailability: Systematic formulation optimization and in-vivo performance.

  2019cites this paper
• Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.

  2019cites this paper
• AKTIVITAS DIURETIK SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) FUROSEMID DIURETIC ACTIVITY OF A SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) OF FUROSEMIDE

  2019cites this paper
• Self-emulsifying drug delivery systems: In vivo evaluation of their potential for oral vaccination.

  2019cites this paper
• Enhanced Oral Delivery of Asenapine Maleate from Solid Lipid Nanoparticles: Pharmacokinetic and Brain Distribution Evaluations

  2018cites this paper
• Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension.

  2018cites this paper
• Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein

  2018influential citation
• Creation of an assessment system for measuring the bitterness of azithromycin-containing reverse micelles

  2018cites this paper